Breaking news on cholesterol
Safely Lowers 'Bad' Cholesterol In Statin-Treated Patients published
Fri, 12 Mar 2010 17:00:00 PDT
People whose "bad" cholesterol and risk of future heart disease stay too high despite cholesterol-lowering statin therapy can safely lower it by adding a drug that mimics the action of thyroid hormone. In a report published in the Mar...
Thyroid Hormone Analogue For Treating High Cholesterol published
Fri, 12 Mar 2010 01:00:00 PDT
An experimental thyroid drug reduces cholesterol without the troublesome side effects experienced by some people on statins, according to a study published today in The New England Journal of Medicine...
Cholesterol Targets For Heart Patients Not Being Met published
Fri, 12 Mar 2010 00:00:00 PDT
Only half of all patients at high risk of heart disease are given correct targets for lowering their cholesterol levels according to a study of 25,250 patients in Germany published online 11 March in the European Heart Journal [1]...
New Drug Candidate Reduces Blood Lipids published
Fri, 12 Mar 2010 00:00:00 PDT
A thyroid-hormone-like substance that works specifically on the liver reduces blood cholesterol with no serious side effects. This according to a clinical trial conducted by researchers from the Swedish medical university Karolinska Institutet, amongst other centres, published in the top-ranking scientific periodical The New England Journal of Medicine...
The New England Journal Of Medicine Publishes Clinical Results On Karo Bio's published
Thu, 11 Mar 2010 20:00:00 PDT
The Swedish biotech company Karo Bio (Reuters: KARO.ST) announced the publication of results from a clinical phase II trial evaluating the company's liver selective thyroid hormone receptor agonist eprotirome and its ability to further reduce serum LDL cholesterol levels in statin-treated patients...
New Drug Reduces Bad Cholesterol And Triglycerides Without Statin Side Effects published
Thu, 11 Mar 2010 03:00:00 PDT
A new drug, eprotirome, has been shown to significantly lower bad cholesterol, triglycerides and Lp(A), without the side effects that statins cause in many people. Results of a study were published in the New England Journal of Medicine. "Our study has shown a dramatic reduction in the dangerous fats that cause heart disease, the number one killer of Americans," said Dr...
Experimental Drug That Mimics Thyroid Hormone Safely Lowers 'Bad' Cholesterol In Statin-Treated Patients published
Thu, 11 Mar 2010 03:00:00 PDT
People whose "bad" cholesterol and risk of future heart disease stay too high despite cholesterol-lowering statin therapy can safely lower it by adding a drug that mimics the action of thyroid hormone. In a report published in the Mar...
Agency For Healthcare Research And Quality News And Numbers: High Cholesterol, Diabetes Lead Drug Spending For The Elderly published
Thu, 11 Mar 2010 02:00:00 PDT
Purchases of cholesterol and diabetes prescription drugs by elderly Medicare beneficiaries reached nearly $19 billion in 2007 - about one-fourth of the approximately $82 billion spent for medications for the elderly, according to the latest AHRQ News and Numbers...
Health Care Partnership Examined In Canadian Medical Association Journal published
Tue, 09 Mar 2010 05:00:00 PDT
A research team from the Laval Centre de sante et de services sociaux, Universite de Montreal and McGill University Health Centre has examined the benefits of greater collaboration between family physicians and community pharmacists for select patients...
Obesity As Protection Against Metabolic Syndrome, Not Its Cause published
Tue, 09 Mar 2010 02:00:00 PDT
The collection of symptoms that is the metabolic syndrome - insulin resistance, high cholesterol, fatty liver, and a greater risk for diabetes, heart disease, and stroke - are all related to obesity, but, according to a review in the March 9th issue of the Cell Press publication Trends in Endocrinology and Metabolism, not in the way you probably think they are...
New Report Warns: If You Take Simvastatin To Control Cholesterol, Watch Out For Infection published
Tue, 02 Mar 2010 05:00:00 PDT
Simvastatin might help us control our cholesterol, but when it comes to infection, it's an entirely different story says a new research study published in the Journal of Leukocyte Biology (http://www.jleukbio.org). In the research report, scientists from Italy show that simvastatin delivers a one-two punch to the immune system...
Mipomersen Phase 3 Study In Patients With Heterozygous Familial Hypercholesterolemia Meets Primary Endpoint published
Fri, 12 Feb 2010 00:00:00 PDT
Genzyme Corp. (NASDAQ: GENZ) and Isis Pharmaceuticals Inc. (NASDAQ: ISIS) announced that the phase 3 study of mipomersen in patients with heterozygous familial hypercholesterolemia (heFH) met its primary endpoint with a highly statistically significant 28 percent reduction in LDL-cholesterol after 26 weeks of treatment, compared with an increase of 5 percent for placebo...
FDA Approves New Indication For Crestor published
Wed, 10 Feb 2010 04:00:00 PDT
On Feb. 8 the U.S. Food and Drug Administration approved the cholesterol-lowering medication Crestor (rosuvastatin) for some patients who are at increased risk of heart disease but have not been diagnosed with it...
Butter Leads To Lower Blood Fats Than Olive Oil published
Wed, 10 Feb 2010 02:00:00 PDT
High blood fat levels normally raise the cholesterol values in the blood, which in turn elevates the risk of atherosclerosis and heart attack. Now a new study from Lund University in Sweden shows that butter leads to considerably less elevation of blood fats after a meal compared with olive oil and a new type of canola and flaxseed oil...
Mizzou Scientist Creates A Chicken Substitute, Providing A Low-Cost, Tasty Way To Add Soy To The Diet published
Fri, 05 Feb 2010 05:00:00 PDT
Sure, some delicacies might taste just like chicken, but they usually feel and look much different. Soy meat alternatives, such as the soy burger, have become more popular recently, with increased sales of eight percent from 2007 to 2008. Now, scientists at the University of Missouri have created a soy substitute for chicken that is much like the real thing...
In Light Of Research About Teens' Heart Disease Risk, Lifestyle Changes Critical published
Thu, 04 Feb 2010 00:00:00 PDT
Pamphlets detailing the warning signs associated with heart disease may soon end up in an unexpected location: your child's pediatrician's office. According to new research from the Centers for Disease Control and Prevention (CDC), one in five American teens has at least one risk factor for developing heart disease in adulthood...
Cholesterol's Link To Heart Disease Gets Clearer - And More Complicated published
Wed, 03 Feb 2010 04:00:00 PDT
By considering molecular-level events on a broader scale, researchers now have a clearer, if more complicated, picture of how one class of immune cells goes wrong when loaded with cholesterol...
Siemens Introduces Cholesterol To The ADVIA Chemistry Concentrated Reagents Portfolio published
Fri, 29 Jan 2010 14:00:00 PDT
Siemens Healthcare Diagnostics has introduced concentrated Cholesterol, the 15th ADVIAŽ Chemistry reagent in concentrated format. ADVIA Chemistry concentrated reagents offer up to 3060 tests per wedge, whilst still giving identical results to the conventional ADVIA non-concentrated reagents...
Pomegranate Extract Stimulates Uterine Contractions published
Thu, 28 Jan 2010 04:00:00 PDT
The team identified beta-sitosterol - a steroid that can inhibit the absorption of cholesterol in the intestine - as the main constituent of pomegranate seed extract. The research suggests that pomegranate extract could be used as a natural stimulant to encourage the uterus to contract during labour...
Even Younger People Should Consider Cholesterol Screening published
Sun, 24 Jan 2010 01:00:00 PDT
If you think heart disease is a disease of the middle aged, think again. Experts recommend that cholesterol screening should begin as early as 20 years of age because it is a key indicator of heart-attack risk, and should be rechecked at least once every five years. Atherosclerosis begins early, says Dr...
Research Published By Standard Process Inc. Scientists About The Effects Of Dietary Intervention On Cholesterol Levels published
Tue, 19 Jan 2010 06:00:00 PDT
In collaboration with the scientists in the Department of Animal Sciences at the University of Wisconsin-Madison, Standard Process scientists have published a study examining the effects of nutritional supplement ingredients on cholesterol levels in Rapacz familial hypercholesterolemic swine or FH swine. Findings of this study were reported in the Journal of Medicinal Food...
Higher Statin Doses Not Always Best At Preventing Coronary Artery Disease published
Tue, 19 Jan 2010 02:00:00 PDT
Statins have proven highly effective at lowering cholesterol. Typically, a treat-to-target approach, which means treating to a target cholesterol level, is taken with statin therapy. However, some experts believe that a tailored approach that uses different dosages based on pateints' risk for cardiovascular disease may be a better strategy for reducing the risk of coronary artery disease...
Treat The Risk, Not The Cholesterol: Study Challenges Current Cholesterol Recommendations published
Tue, 19 Jan 2010 01:00:00 PDT
A new study by the University of Michigan Medical School and VA Ann Arbor Health System challenges the medical thinking that the lower the cholesterol, the better...
Impax Laboratories Confirms Patent Challenge Relating To WELCHOL(R) 625 Mg Tablets published
Mon, 18 Jan 2010 04:00:00 PDT
Impax Laboratories, Inc. (NASDAQ:IPXL) confirms that it has initiated a challenge of patents listed by Daiichi Sankyo, Inc. in connection with its WELCHOLŽ (Colesevelam HCl) tablets, 625 mg. Impax filed its Abbreviated New Drug Application ("ANDA") containing a paragraph IV certification for a generic version of WELCHOLŽ with the U.S. Food & Drug Administration ("FDA")...
Despite FDA Warnings, The Monitoring Of High-Risk Medications Remains Unchanged published
Wed, 13 Jan 2010 05:00:00 PDT
A new study concludes that many doctors appear to have largely ignored a Food and Drug Administration warning to screen users of new antipsychotic drugs for high blood sugar and cholesterol, which poses risks to their health and raises questions about the efficacy of warning protocols in general...
)
|
|
